pharma · Acute Myeloid Leukemias · Breast Cancer
Syndax Pharmaceuticals
Syndax Pharmaceuticals trial registry — 56 ClinicalTrials.gov studies with program phase, status, and indication context.
730 3rd Ave, Floor 9, New York, NY 10017, US HQ
325 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 730 3rd Ave, Floor 9, New York, NY 10017, US
- Employees
- 325
- Programs
- 47
- Drugs
- 29
- Patents
- 6
Syndax Pharmaceuticals clinical trials
Registry index of 56 ClinicalTrials.gov studies linked to Syndax Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Syndax Pharmaceuticals trial registry — 56 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Syndax Pharmaceuticals.
-
SNDX-5613-0710 — Phase 3
Clinical update -
SNDX-5613-0708 — Phase 1
Clinical update -
SNDX-5613-0700 — Phase 2
Clinical update -
AXATILIMAB — Phase 2
Clinical update -
Revumenib — Phase 1
Clinical update -
Revumenib — Phase 2
Clinical update -
Revumenib — Phase 1
Clinical update -
Axatilimab — Phase 1
Clinical update
Trial registry
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CTIS ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗